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The Supporting Information contains an integration to the experimental section with details 
about calculation of recoveries, matrix effect and process efficiency, a general figure for 
GCB SPE protocol (Figure S1), results of the optimization experiments of the GCB 
procedure from standards (Table S1), list of peptide standards with related mass, GRAVY 
value, molecular weight, pI and MRM acquisition conditions (Table S2), plots showing the 
S-1
trend of standard peptide recoveries under the 6 procedures described in Table S2 as a 
function of GRAVY, MW and pI (Figure S2), results on the performance of the final GCB 
SPE method from spiked urine samples (Table S3), plots showing the trend of standard 
peptide recoveries under the final procedure as a function of GRAVY value, MW and pI for 
standards in solvent and spiked urine samples (Figure S3), figure on the reproducibility of the 
chromatographic separation by iHILIC Fusion with chromatograms, boxplot of log2(area) and 
multiscatterplots with Pearson correlation coefficient (Figure S4).
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Integration to section “Preparation of Urine Samples and Peptide Extraction”: 
calculation of recovery, matrix effect and process efficiency.
Recovery, matrix effect and process efficiency were calculated from three sets of 
experiments, namely urine samples spiked with the standard peptides before (set 1) and after 
(set 2) the GCB enrichment and clean-up, and neat standard solutions (set 3). Absolute peak 
areas (i.e., without normalization) were measured and used in the following equations.
Recovery (RE%) was calculated using equation 1:
RE% = (Areaset1/Areaset2) × 100 (1)
Matrix effect (ME%) was calculated using equation 2:
ME% = (Areaset2/Areaset3) × 100 (2)
The overall process efficiency (PE%) can be obtained by applying one of the two following 
equations:
PE% = (Areaset1/Areaset3) × 100 (3a)
PE% = RE × ME . (3b)
The experiments were performed using 100 ng of each standard peptide.
Figure S1. Optimization protocol for GCB applied to short peptide recovery from standard 
solutions.
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Table S1. Test with standard peptide mixture. Ten mL of loading buffer (LB) were spiked 
with 100 ng of each standard peptide. The general protocol and names of each step are 
reported in Figure S1. The detailed composition of the loading buffer (LB), washing buffer 
(WB) and elution buffer (EB) is reported below the table.
Exp 1 Exp 2 Exp 3 Exp 4 Exp 5a Exp 6 Urineb
GCB Amount 250 mg 250 mg 250 mg 250 mg 250 mg 250 mg 500 mg
Washing a 5 mL EB2
5 mL 
EB2
5 mL 
EB3
5 mL 
EB4
5 mL 
EB5
5 mL 
EB6
5 mL 
EB5
Washing b 5 mL EB1
5 mL 
EB1
5 mL 
EB1
5 mL 
EB1
5 mL 
WB2
5 mL 
WB2
5 mL 
WB2
GCB Activation 10 mL LB1
10 mL 
LB1
10 mL 
LB1
10 mL 
LB1
10 mL 
LB1
10 mL 
LB1
10 mL 
LB1
GCB Conditioning 10 mL LB2 -
10 mL 
LB3
10 mL 
LB3
10 mL 
LB3
10 mL 
LB3
10 mL 
LB3
Sample Loading 10 mL LB2
10 mL 
LB1
10 mL 
LB3
10 mL 
LB3
10 mL 
LB3
10 mL 
LB3
2 mL 
urine + 
8 mL 
LB3
Washing 1 2 mL LB2
2 mL 
LB1
2 mL 
LB3
2 mL 
LB3
2 mL 
LB3
2 mL 
LB3
2 mL 
LB3
Washing 2 - - - 0.5 mL WB1
0.5 
mL 
WB1
0.5 mL 
WB1
0.5 mL 
WB1
Elution 1 5 mL EB1
5 mL 
EB1
5 mL 
EB1
10 mL 
EB4
10 mL 
EB5
10 mL 
EB6
10 mL 
EB5
Elution 2 10 mL EB2
10 mL 
EB2
10 mL 
EB3 - - - -
Backflushing 
elution No No No Yes Yes Yes Yes
Recovery (%) 12-93%
15-
100% 32-99% 61-99%
61-
100% 61-97%
60-
100%
RSD (%) 10-18% 9-15% 13-22% 15-35% 8-17% 14-23% 9-17%
LB1: H2O with 0.1 mol L-1 HCl
LB2: H2O with 50 mmol L-1 HCOOH
LB3: H2O 20 mmol L-1 TFA
WB1: MeOH 
WB2: MeOH 20 mmol L-1 TFA
EB1: MeOH 50 mmol L-1 HCOOH
EB2: CH2Cl2/MeOH, 80:20 (v/v) 50 mmol L-1 HCOOH
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EB3: CH2Cl2/MeOH, 80:20 (v/v) 10 mmol L-1 TMAC
EB4: CH2Cl2/MeOH, 80:20 (v/v) 10 mmol L-1 TMAC 50 mmol L-1 HCOOH
EB5: CH2Cl2/MeOH, 80:20 (v/v) 20 mmol L-1 TFA
EB6: CH2Cl2/MeOH, 80:20 (v/v) 50 mmol L-1 TFA
afinal conditions for pure solvents
bfinal conditions for urine
Table S2. List of peptide standards with related mass, Grand average of hydropathicity 
(GRAVY) value, molecular weight (MW), isoelectric point (pI) and MRM acquisition 
conditions (m/z of precursor ions and product ions, collision energy and S-lens values).
Peptide MW GRAVY index pI
Precursor 
ion (m/z) 
[M+H]+
Product 
ions (m/z)
Collision 
energy 
(eV)
S-
lens 
(V)
285 110 28 96KH 283.1644 -3.55 8.75 285 156 14 96
229 68 37 80PL 228.1474 1.1 5.95 229 70 19 80
229 68 37 80PI 228.1474 1.45 5.95 229 70 19 80
229 86 32 70LP 228.1474 1.1 5.95 229 116 16 70
243 110 25 80SH 242.1015 -2 6.45 243 156 15 80
412 110 34 100KHK 411.2594 -3.67 10.00 412 231 25 100
342 70.5 31 100IPI 341.2315 2.47 5.53 342 229 17 100
342 70.5 31 100LPL 341.2315 2 5.52 342 229 17 100
323 70 33 129RF 321.1901 -0.85 9.75 323 175 20 129
344 116 14 87VEP 343.1743 -0.3 3.99 344 229 13 87
428 173 25 150VRGP 427.2543 -0.58 9.72 428 239 27 150
433 86 23 113GDLE 432.1856 -0.9 4.08 433 261 19 113
439 211 17 111IPPL 438.2842 1.28 5.52 439 326 19 111
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Figure S2. Plots showing the trend of standard peptide recoveries under the 6 procedures 
described in Table S2 as a function of GRAVY value (a), MW (b) and pI (c).
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Table S3. Method performance of the GCB clean-up of short peptides from spiked urine 
samples.
Recovery 
(%)
Matrix 
effect 
(%)
Process 
efficiency 
(%)
KH 76% 96% 73%
PL 75% 115% 86%
PI 75% 111% 83%
LP 87% 109% 95%
SH 60% 85% 51%
KHK 93% 90% 84%
IPI 94% 88% 83%
LPL 87% 86% 75%
RF 100% 102% 102%
VEP 91% 116% 106%
VRGP 99% 114% 113%
GDLE 90% 114% 103%
IPPL 89% 103% 92%
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Figure S3. Plots showing the trend of standard peptide recoveries under the final procedure 
described in Table S2 as a function of GRAVY value (a), MW (b) and pI (c) for standards in 
solvent (Experiment 5) and spiked urine samples.
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Figure S4. Reproducibility of the chromatographic separation by iHILIC Fusion. 
Chromatograms (a) and log2(area) (b) of the identified peptides across the three technical 
replicates for each experimental replicate. Multiscatterplots for HILIC runs with Pearson 
correlation coefficient (c).
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